Richert, I., Berchard, P., Abbes, L., Novikov, A., Chettab, K., Vandermoeten, A., . . . Dutour, A. (2023). A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Cancers, 15(18), 4635. https://doi.org/10.3390/cancers15184635
Chicago Style (17th ed.) CitationRichert, Iseulys, et al. "A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages." Cancers 15, no. 18 (2023): 4635. https://doi.org/10.3390/cancers15184635.
MLA (9th ed.) CitationRichert, Iseulys, et al. "A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages." Cancers, vol. 15, no. 18, 2023, p. 4635, https://doi.org/10.3390/cancers15184635.